Accellacare US Inc — Raleigh, North Carolina

Accellacare US Inc is a clinical research site located in Raleigh, North Carolina, United States 27609.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Accellacare US Inc has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Cardiovascular Disease and Lipoprotein(a).

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Raleigh

Browse all research sites in North Carolina · View every site in Raleigh

• WakeMed Health and Hospitals
• UNC Health REX Hospital
• University of North Carolina at Chapel Hill
• Duke University Medical Center
• Wake Med Health & Hospital
• University of North Carolina Urogynecology and Reconstructive Pelvic Surgery at REX
• Wake Medical Hospital
• WakeMed North Hospital
• Ohio State University-Telemedicine
• Central Regional Hospital
• University of North Carolina
• Rex Hospital

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accellacare US Inc?

Accellacare US Inc has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accellacare US Inc conducted?

Accellacare US Inc has 2 clinical trials on record, with 2 currently active. Their work covers Cardiovascular Disease and Lipoprotein(a).

Is Accellacare US Inc accredited by Crixeo Clinical Trials?

Accellacare US Inc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accellacare US Inc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.